Is a complete ZVRA research report available?

No complete published report is available for Zevra Therapeutics, Inc. (ZVRA) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

Zevra Therapeutics, Inc. (ZVRA)

NASDAQ: ZVRA · USD

$10.3

+0.24 (+2.4%)· Recorded snapshot

Market cap	611.4M
Revenue (ttm)	136.1M
Net income (ttm)	57.2M
EPS (ttm)	$0.96
Shares out	59.4M
P/E (trailing)	10.7x
P/E (forward)	12.0x
Volume	826,473
Beta	0.98

Market data

Price

Recent price action with selectable time range.

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
EXAS	Exact Sciences Corp	—	—	—	—	—	—	Aanhouden

Metric	Value
Amount currency	USD
CIK code	0001434647
Company name	Zevra Therapeutics, Inc.
Country	United States
Country code	US
CUSIP number	488445206
Earnings date	2026-11-03
Earnings time	amc
Employees	61
Employees change	2
Employees growth	3.39%
Enterprise value	$391.3M
Exchange	NASDAQ
Financial currency	USD
Financial report date	2026-06-30
First seen	2026-05-09
Fiscal year end	December
Founded	2006
In index	RUSSELL2000
Industry	Biotechnology
IPO date	2015-04-16
Is primary listing	Yes
Is SPAC	No
ISIN number	US4884452065
Last 10-K release date	2026-03-09
Last earnings date	2026-08-05
Last refreshed	2026-10-28
Last stock split date	2020-12-28
Last stock split type	Reverse
Market cap	$611.4M
Market cap category	Small-Cap
Next earnings date	2026-11-03
Options	Yes
Price	$10.30
Price currency	USD
Sector	Healthcare
SIC code	2834
Stock price date	2026-10-28
Symbol	ZVRA
U.S. state	Massachusetts
Website	https://www.zevra.com

Metric

Value

Amount currency

USD

CIK code

0001434647

Company name

Zevra Therapeutics, Inc.

Country

United States

Country code

CUSIP number

488445206

Earnings date

2026-11-03

Earnings time

amc

Employees

Employees change

Employees growth

3.39%

Enterprise value

$391.3M

Exchange

NASDAQ

Financial currency

USD

Financial report date

2026-06-30

First seen

2026-05-09

Fiscal year end

December

Founded

2006

In index

RUSSELL2000

Industry

Biotechnology

IPO date

2015-04-16

Is primary listing

Yes

Is SPAC

ISIN number

US4884452065

Last 10-K release date

2026-03-09

Last earnings date

2026-08-05

Last refreshed

2026-10-28

Last stock split date

2020-12-28

Last stock split type

Reverse

Market cap

$611.4M

Market cap category

Small-Cap

Next earnings date

2026-11-03

Options

Yes

Price

$10.30

Price currency

USD

Sector

Healthcare

SIC code

2834

Stock price date

2026-10-28

Symbol

ZVRA

U.S. state

Massachusetts

Website

https://www.zevra.com

Metric	Value
Adjusted P/E ratio	16.88x
Earnings yield	9.33%
EV/Earnings	6.79x
EV/EBIT	9.95x
EV/EBITDA	9.58x
EV/FCF	11.91x
EV/Sales	2.86x
FCF / EV yield	8.4%
FCF yield	5.36%
Forward EV/Sales	2.36x
Forward P/E	11.95x
Forward P/S	3.69x
Graham number	8.90188
Graham upside	-13.15%
P/(FCF - SBC) ratio	31.22x
P/(OCF - SBC) ratio	30.03x
P/B ratio	2.74x
P/E ratio	10.72x
P/FCF ratio	18.66x
P/OCF ratio	18.22x
P/S ratio	4.47x
Price / tangible book value	2.94x
Price/EBITDA ratio	15.01x
Sector forward P/E	23.56x
Sector P/E	50.08x

Metric

Value

Adjusted P/E ratio

16.88x

Earnings yield

9.33%

EV/Earnings

6.79x

EV/EBIT

9.95x

EV/EBITDA

9.58x

EV/FCF

11.91x

EV/Sales

2.86x

FCF / EV yield

8.4%

FCF yield

5.36%

Forward EV/Sales

2.36x

Forward P/E

11.95x

Forward P/S

3.69x

Graham number

8.90188

Graham upside

-13.15%

P/(FCF - SBC) ratio

31.22x

P/(OCF - SBC) ratio

30.03x

P/B ratio

2.74x

P/E ratio

10.72x

P/FCF ratio

18.66x

P/OCF ratio

18.22x

P/S ratio

4.47x

Price / tangible book value

2.94x

Price/EBITDA ratio

15.01x

Sector forward P/E

23.56x

Sector P/E

50.08x

Metric	Value
EBIT margin	28.71%
EBITDA margin	29.8%
Effective tax rate	15.91%
FCF margin	23.98%
Gross margin	95.46%
Operating margin	28.71%
Pretax margin	50.92%
Profit margin	42.82%
Profit per employee	$938,475
Profitable quarters	3
Profitable years	1
Revenue per employee	$2.2M
ROA	8.74%
ROA (5Y)	-11.91%
ROCE	15.38%
ROE	34.8%
ROE (5Y)	-48.82%
ROIC	1,679.05%
ROIC (5Y)	-126.85%
SBC / revenue	9.65%
Tax / revenue	8.1%

Metric

Value

EBIT margin

28.71%

EBITDA margin

29.8%

Effective tax rate

15.91%

FCF margin

23.98%

Gross margin

95.46%

Operating margin

28.71%

Pretax margin

50.92%

Profit margin

42.82%

Profit per employee

$938,475

Profitable quarters

Profitable years

Revenue per employee

$2.2M

ROA

8.74%

ROA (5Y)

-11.91%

ROCE

15.38%

ROE

34.8%

ROE (5Y)

-48.82%

ROIC

1,679.05%

ROIC (5Y)

-126.85%

SBC / revenue

9.65%

Tax / revenue

8.1%

Metric	Value
EPS growth (Q)	-88.43%
EPS growth (QoQ)	-76.67%
EPS growth years	1
FCF growth (QoQ)	175.34%
FCF growth 5Y	22.56%
Gross profit growth	191.06%
Gross profit growth (Q)	182.46%
Gross profit growth 3Y	102.78%
Gross profit growth 5Y	37.54%
Net income growth	2,103.59%
Net income growth (Q)	-88.29%
Net income growth (QoQ)	-76.89%
Net income growth years	1
OCF growth (QoQ)	177.3%
OCF growth 5Y	22.91%
Operating income growth 5Y	36.11%
Revenue growth	119.4%
Revenue growth (Q)	53.25%
Revenue growth (QoQ)	9.51%
Revenue growth 3Y	101.86%
Revenue growth 5Y	36.81%
Revenue growth quarters	6
Revenue growth years	1

Metric

Value

EPS growth (Q)

-88.43%

EPS growth (QoQ)

-76.67%

EPS growth years

FCF growth (QoQ)

175.34%

FCF growth 5Y

22.56%

Gross profit growth

191.06%

Gross profit growth (Q)

182.46%

Gross profit growth 3Y

102.78%

Gross profit growth 5Y

37.54%

Net income growth

2,103.59%

Net income growth (Q)

-88.29%

Net income growth (QoQ)

-76.89%

Net income growth years

OCF growth (QoQ)

177.3%

OCF growth 5Y

22.91%

Operating income growth 5Y

36.11%

Revenue growth

119.4%

Revenue growth (Q)

53.25%

Revenue growth (QoQ)

9.51%

Revenue growth 3Y

101.86%

Revenue growth 5Y

36.81%

Revenue growth quarters

Revenue growth years

Metric	Value
Capital expenditures	$-775,000
Depreciation and amortization	$1.5M
EBIT	$39.1M
EBITDA	$40.6M
EPS	$0.96
FCF per share	$0.55
Financing cash flow	$-42.1M
Free cash flow	$32.6M
Free cash flow minus SBC	$19.5M
Gross profit	$129.9M
Income taxes	$11M
Investing cash flow	$106.7M
Net borrowing	$-60.1M
Net cash flow	$97.6M
Net income	$57.2M
Operating cash flow minus SBC	$20.3M
Operating income	$39.1M
Revenue	$136.1M
Stock-based compensation	$13.1M

Metric

Value

Capital expenditures

$-775,000

Depreciation and amortization

$1.5M

EBIT

$39.1M

EBITDA

$40.6M

EPS

$0.96

FCF per share

$0.55

Financing cash flow

$-42.1M

Free cash flow

$32.6M

Free cash flow minus SBC

$19.5M

Gross profit

$129.9M

Income taxes

$11M

Investing cash flow

$106.7M

Net borrowing

$-60.1M

Net cash flow

$97.6M

Net income

$57.2M

Operating cash flow minus SBC

$20.3M

Operating income

$39.1M

Revenue

$136.1M

Stock-based compensation

$13.1M

Metric	Value
Altman Z-Score	3.92
Book value per share	$3.67
Debt / EBITDA	0.04
Debt / equity	0.01
Debt / FCF	0.05
Goodwill	$4.7M
Interest coverage	6.84
Long-term assets	$51.4M
Long-term liabilities	$36.4M
Net cash (debt)	$220.1M
Net cash / market cap	36.16%
Net cash growth	56.82%
Net debt / EBITDA	-5.43
Net debt / equity	-1.01
Net debt / FCF	-6.75
Piotroski F-Score	5
Property, plant and equipment	$2.3M
Shareholders' equity	$217.7M
Tangible book value	$207.2M
Tangible book value per share	$3.49
Total assets	$302.7M
Total cash	$221.6M
Total debt	$1.5M
Total liabilities	$85.1M
WACC	10.41%

Metric

Value

Altman Z-Score

3.92

Book value per share

$3.67

Debt / EBITDA

0.04

Debt / equity

0.01

Debt / FCF

0.05

Goodwill

$4.7M

Interest coverage

6.84

Long-term assets

$51.4M

Long-term liabilities

$36.4M

Net cash (debt)

$220.1M

Net cash / market cap

36.16%

Net cash growth

56.82%

Net debt / EBITDA

-5.43

Net debt / equity

-1.01

Net debt / FCF

-6.75

Piotroski F-Score

Property, plant and equipment

$2.3M

Shareholders' equity

$217.7M

Tangible book value

$207.2M

Tangible book value per share

$3.49

Total assets

$302.7M

Total cash

$221.6M

Total debt

$1.5M

Total liabilities

$85.1M

WACC

10.41%

Metric	Value
Asset turnover	0.49
Current assets	$251.3M
Current liabilities	$48.6M
Current ratio	5.17
Inventory turnover	3.47
Net working capital	$-18.3M
Quick ratio	5.02
Working capital	$202.7M
Working capital turnover	0.68

Metric

Value

Asset turnover

0.49

Current assets

$251.3M

Current liabilities

$48.6M

Current ratio

5.17

Inventory turnover

3.47

Net working capital

$-18.3M

Quick ratio

5.02

Working capital

$202.7M

Working capital turnover

0.68

Metric	Value
Buyback yield / dilution	-13.46%
Dividend yield	0%
Shareholder yield	-13.46%

Metric

Value

Buyback yield / dilution

-13.46%

Dividend yield

Shareholder yield

-13.46%

Metric	Value
10Y price change	-83.99%
10Y return CAGR	-16.74%
10Y total return	-83.99%
150-day SMA	$11.28
1D price change	2.39%
1M price change	-8.33%
1M total return	-8.33%
1W price change	-3.34%
1W total return	-3.34%
1Y price change	-8.66%
1Y return CAGR	-8.67%
1Y total return	-8.66%
20-day SMA	$10.40
200-day SMA	$10.73
3M price change	4.22%
3M total return	4.22%
3Y price change	133.18%
3Y return CAGR	32.6%
3Y total return	133.18%
50-day SMA	$11.24
50-day SMA vs 200-day SMA	50over200
52-week high	$15.04
52-week high date	2026-07-08
52-week low	$8.01
52-week low date	2025-12-19
5Y price change	0.2%
5Y return CAGR	0.04%
5Y total return	0.2%
6M price change	3.16%
6M total return	3.16%
All-time high	$418.40
All-time high date	2015-08-14
All-time low	$1.94
All-time low date	2020-05-21
Average true range (ATR)	$0.48
Average volume	800.3K
Beta (1Y)	2.1
Beta (2Y)	1.03
Beta (5Y)	0.98
Change from 52-week high	-31.53%
Change from 52-week low	28.53%
Change from all-time high	-97.58%
Change from all-time low	422.73%
Change from open	2.85%
Day's gap	-0.5%
Dollar volume	$8.5M
High price	$10.31
Low price	$10.01
Monthly RSI	52.06
Open price	$10.01
Position in 52-week range	95%
Premarket change	0.94%
Premarket close	$10.06
Premarket price	$10.15
Previous close	$10.06
Price vs 150-day SMA	-10.3%
Price vs 20-day SMA	-2.72%
Price vs 200-day SMA	-5.71%
Price vs 50-day SMA	-9.97%
Relative volume	1.03
RSI	43.31
Sharpe ratio	0.09
Sharpe ratio (3Y)	0.72
Sharpe ratio (5Y)	0.25
Sortino ratio	0.22
Sortino ratio (3Y)	1.23
Sortino ratio (5Y)	0.47
Volume	826.5K
Weekly RSI	46.68
YTD price change	12.95%
YTD total return	12.95%

Metric

Value

10Y price change

-83.99%

10Y return CAGR

-16.74%

10Y total return

-83.99%

150-day SMA

$11.28

1D price change

2.39%

1M price change

-8.33%

1M total return

-8.33%

1W price change

-3.34%

1W total return

-3.34%

1Y price change

-8.66%

1Y return CAGR

-8.67%

1Y total return

-8.66%

20-day SMA

$10.40

200-day SMA

$10.73

3M price change

4.22%

3M total return

4.22%

3Y price change

133.18%

3Y return CAGR

32.6%

3Y total return

133.18%

50-day SMA

$11.24

50-day SMA vs 200-day SMA

50over200

52-week high

$15.04

52-week high date

2026-07-08

52-week low

$8.01

52-week low date

2025-12-19

5Y price change

0.2%

5Y return CAGR

0.04%

5Y total return

0.2%

6M price change

3.16%

6M total return

3.16%

All-time high

$418.40

All-time high date

2015-08-14

All-time low

$1.94

All-time low date

2020-05-21

Average true range (ATR)

$0.48

Average volume

800.3K

Beta (1Y)

2.1

Beta (2Y)

1.03

Beta (5Y)

0.98

Change from 52-week high

-31.53%

Change from 52-week low

28.53%

Change from all-time high

-97.58%

Change from all-time low

422.73%

Change from open

2.85%

Day's gap

-0.5%

Dollar volume

$8.5M

High price

$10.31

Low price

$10.01

Monthly RSI

52.06

Open price

$10.01

Position in 52-week range

95%

Premarket change

0.94%

Premarket close

$10.06

Premarket price

$10.15

Previous close

$10.06

Price vs 150-day SMA

-10.3%

Price vs 20-day SMA

-2.72%

Price vs 200-day SMA

-5.71%

Price vs 50-day SMA

-9.97%

Relative volume

1.03

RSI

43.31

Sharpe ratio

0.09

Sharpe ratio (3Y)

0.72

Sharpe ratio (5Y)

0.25

Sortino ratio

0.22

Sortino ratio (3Y)

1.23

Sortino ratio (5Y)

0.47

Volume

826.5K

Weekly RSI

46.68

YTD price change

12.95%

YTD total return

12.95%

Metric	Value
Float	53.9M
Float percentage	90.72%
Shares change (QoQ)	1.84%
Shares change (YoY)	13.46%
Shares held by insiders	1.22%
Shares held by institutions	69.32%
Shares outstanding	59.4M
Short % of float	13.27%
Short % of shares	12.04%
Short ratio	7.5 days

Metric

Value

Float

53.9M

Float percentage

90.72%

Shares change (QoQ)

1.84%

Shares change (YoY)

13.46%

Shares held by insiders

1.22%

Shares held by institutions

69.32%

Shares outstanding

59.4M

Short % of float

13.27%

Short % of shares

12.04%

Short ratio

7.5 days

Zevra Therapeutics, Inc. (ZVRA)

Price

Financial snapshot

Fair-value bridge

Latest news · ZVRA

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All ZVRA indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on ZVRA

Frequently asked questions